Gilead finds ‘critical holes’ in the government’s HIV patent case against it

Gilead’s hoping for a swift end to its HIV patent battle with HHS, filing for a summary judgment on Thursday. If the motion is granted in Gilead’s favor, the case would be dismissed without a trial.

The US filed suit against Gilead back in 2019, alleging that the sale of...

Click to view original post